YD Bio Ltd
YDES
10 hedge funds and large institutions have $3.42M invested in YD Bio Ltd in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.25% more ownership
Funds ownership: 0% → 0.25% (+0.25%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$923K |
| 2 |
Cerity Partners
New York
|
+$563K |
| 3 |
HF
HRT Financial
New York
|
+$553K |
| 4 |
CCMW
Cypress Capital Management (Wyoming)
Sheridan,
Wyoming
|
+$521K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$179K |
Top Sellers
YDES Hedge Fund Activity: Q3 2025 in Review
10 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in YD Bio Ltd (YDES) for Q3 2025, worth a combined $3.42M.
Buyers outnumbered sellers: 10 funds opened new YDES positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $923K.
- 10 institutional investors held YD Bio Ltd (YDES) as of Q3 2025, up from 0 in Q2 2025.
- Funds reported $3.42M of YD Bio Ltd stock for Q3 2025.
- 10 funds opened new YD Bio Ltd positions in Q3 2025 and 0 closed out, a net change of +10 holders.
- The largest YD Bio Ltd buyer in Q3 2025 was Geode Capital Management, an estimated $923K added.
Based on aggregated 13F filings for Q3 2025.